Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Mynarek

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Pediatric Blood & Cancer|February 11, 2024
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studiesThomas Traunwieser, Elena Loos, Holger Ottensmeier, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Cancer|October 21, 2021
Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patientsRosdali Y Diaz Coronado, Martin Mynarek, Christian Koelsche, et al.
Eclinicalmedicine|July 1, 2026
Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort studyStacey Richardson, Debbie Hicks, Melissa Gough, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
The Lancet. Child & Adolescent Health|May 18, 2026
Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort studyStacey Richardson, Debbie Hicks, Melissa Gough, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
The Oncologist|March 10, 2019
Newly Diagnosed Metastatic Intracranial Ependymoma in Children: Frequency, Molecular Characteristics, Treatment, and Outcome in the Prospective HIT SeriesMartin Benesch, Martin Mynarek, Hendrik Witt, et al.
Neuro-Oncology|August 22, 2024
Distinct relapse pattern across molecular ependymoma typesDenise Obrecht-Sturm, Melanie Schoof, Alicia Eckhardt, et al.
Neuro-Oncology|January 30, 2023
Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroupsSvenja Tonn, Andrey Korshunov, Denise Obrecht, et al.
Pediatric Blood & Cancer|February 11, 2024
Survivors of infant atypical teratoid/rhabdoid tumors present with severely impaired cognitive functions especially for fluid intelligence and visual processing: data from the German brain tumor studiesThomas Traunwieser, Elena Loos, Holger Ottensmeier, et al.
Neuro-Oncology|April 5, 2022
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing diseaseMichael Bockmayr, Kim Harnisch, Lara C Pohl, et al.
Acta Neuropathologica|November 27, 2019
Molecular subgrouping of primary pineal parenchymal tumors reveals distinct subtypes correlated with clinical parameters and genetic alterationsElke Pfaff, Christian Aichmüller, Martin Sill, et al.
Cancer|October 21, 2021
Primary central nervous system sarcoma with DICER1 mutation-treatment results of a novel molecular entity in pediatric Peruvian patientsRosdali Y Diaz Coronado, Martin Mynarek, Christian Koelsche, et al.
Eclinicalmedicine|July 1, 2026
Therapy and biomarker dependent progression-free survival in infant sonic hedgehog medulloblastoma: a multi-national retrospective cohort studyStacey Richardson, Debbie Hicks, Melissa Gough, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|August 18, 2015
Strategies to improve the quality of survival for childhood brain tumour survivorsGesche Tallen, Anika Resch, Gabriele Calaminus, et al.
The Lancet. Child & Adolescent Health|May 18, 2026
Integrated biomarker and treatment correlates of prognosis in infant non-WNT/non-SHH medulloblastoma: a multinational retrospective cohort studyStacey Richardson, Debbie Hicks, Melissa Gough, et al.
Pageof 10